Business Standard

Glenmark acquires Wockhardt's key OTC brands in US for undisclosed sum

Deal includes approved ANDAs for famotidine tablets, used in treatment and prevention of ulcers stomach and intestinal ulcers

Glenmark Pharmaceuticals

Sohini Das Mumbai
Mumbai-based Glenmark Pharmaceuticals said it has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the US for an undisclosed sum. The move is expected to strengthen the acquirer's OTC presence in the US. 

The acquisition by the company's fully-owned subsidiary, Glenmark Pharmaceuticals Inc, USA, includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg, used to treat and prevent ulcers in the stomach and intestine, the company said in a statement.

Glenmark did not disclose the financial details. The stock ended at Rs 387, up 0.8 per cent up on the

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 28 2022 | 3:32 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to